Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

June 18th 2020, Silver Chartbook – Make it your own

Make it your own Trading is often compared to professional sports. This not only due to the competitive element. To produce outstanding performance different methodologies are required to reach elevated performance levels. Successful market participation is not achiev...

Interference Most Foul: When Speculation Becomes Reality

To put it mildly, the business of financial forecasting is not only an inexact science, it is a magnified case study in handicapping, the likes of which you find in sports betting such as horse racing or basketball. You take a basket of data inputs, such as the last fiv...

A Boomer's Plea

I was born in the 1950s, a decade dominated by thousands of WWII servicemen marrying and starting families in the creation of the largest demographic in history, the "Baby Boom Generation." The 1950s saw Elvis Presley dominate the entertainment industry with ten #1 hits a...

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....

My Second-Worst Nightmare

It was only a few hours ago that I was cruising through a lovely early-autumn Friday afternoon preparing for one of the last weekends at the marina for the 2019 season when I came across the much-heralded (and often misinterpreted) COT report. I was on the way up the ea...

Understanding Trading Risks Is Crucial For Your Success

This article will most likely open your eyes and see a side of trading you usually don't think about or possibly don't understand, even though it is critical for your long term success as a trader and investor. Not many people talk about trading risks and for a good reason...

Dissecting the Stock Bubble Debate: Flow Versus Value

"For every action, there is an equal and opposite reaction." —Sir Isaac Newton (Newton's Third Law) In nature, where everything moves freely absent human interference, her omnipotent forces are allowed to manifest themselves in manners that create a living ecosystem t...

Will People Accept Rampant Inflation? Hell, No!

The Weekly Missive, which usually arrives over the weekend (sometimes on Friday, sometimes on Sunday) was delayed this weekend for one reason: I had to change it. I started out last week with an idea that was leaning in the direction of full-on capitulation in the sen...

Cypress Development Makes Lithium Flow Sheet Enhancements

On Aug. 29, Cypress Development Corp. (CYP:TSX.V; CYDVF:OTCQB; C1Z1:FSE) announced the successful completion of the slurry rheology and filtration studies that are an integral part of the prefeasibility study (PFS) for its Clayton Valley clay-hosted lithium project, l...

First Cobalt, Last Man Standing in North American Cobalt Sector

First Cobalt Corp. (FCC:TSX.V; FTSSF:OTCQX; FCC:ASX) announced it has entered into a US$5 million loan facility with Glencore International Plc (GLEN:LSE) to complete advanced engineering, metallurgical testing, field work and permitting associated with the recommiss...
1 2 3 4 5 6 7 8 9 10 ...